HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,272,142 | -43.2% | 315,668 | -90.0% | 1.63% | -15.1% |
| Q2 2023 | $2,241,256 | -4.1% | 3,156,699 | 0.0% | 1.92% | -0.3% |
| Q1 2023 | $2,335,957 | +2.0% | 3,156,699 | 0.0% | 1.93% | +16.4% |
| Q4 2022 | $2,290,816 | -25.2% | 3,156,699 | 0.0% | 1.66% | -8.8% |
| Q3 2022 | $3,062,000 | -49.2% | 3,156,699 | 0.0% | 1.82% | -53.5% |
| Q2 2022 | $6,029,000 | -61.6% | 3,156,699 | 0.0% | 3.91% | -49.5% |
| Q1 2022 | $15,689,000 | -34.2% | 3,156,699 | 0.0% | 7.73% | -10.5% |
| Q4 2021 | $23,833,000 | -4.4% | 3,156,699 | 0.0% | 8.64% | +20.0% |
| Q3 2021 | $24,938,000 | +641.3% | 3,156,699 | 0.0% | 7.19% | +733.5% |
| Q2 2021 | $3,364,000 | -94.9% | 3,156,699 | 0.0% | 0.86% | -94.4% |
| Q1 2021 | $66,038,000 | +36.1% | 3,156,699 | +8.1% | 15.37% | +37.1% |
| Q4 2020 | $48,525,000 | -2.2% | 2,921,405 | 0.0% | 11.21% | -43.9% |
| Q3 2020 | $49,635,000 | +2.4% | 2,921,405 | 0.0% | 20.00% | +43.7% |
| Q2 2020 | $48,495,000 | +43.3% | 2,921,405 | 0.0% | 13.92% | +37.5% |
| Q1 2020 | $33,830,000 | -21.7% | 2,921,405 | 0.0% | 10.12% | +7.8% |
| Q4 2019 | $43,208,000 | +8.3% | 2,921,405 | 0.0% | 9.39% | -22.2% |
| Q3 2019 | $39,906,000 | +5.1% | 2,921,405 | 0.0% | 12.07% | +18.6% |
| Q2 2019 | $37,978,000 | +37.3% | 2,921,405 | 0.0% | 10.18% | +34.3% |
| Q1 2019 | $27,666,000 | – | 2,921,405 | – | 7.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |